Viking Therapeutics (VKTX) shares have seen some interesting moves over the past month, climbing more than 16%. Investors are watching closely, with a particular focus on how the biotech’s pipeline ...

B Riley has initiated Viking Therapeutics at buy saying that the company lead obesity treatment, VK2735, could have "long-term disruptive potential." The investment bank has a $109 price target (~111% ...

Viking Therapeutics is developing drugs for obesity and non-alcoholic fatty liver disease. The company has no revenue and may have none for several years as it works to get drug approval. Viking could ...

-- U.S. river cruise operator Viking Cruises Ltd. plans to issue $250 million in seniornotes. -- The company will primarily use the proceeds to invest in new river vessels and expandinto coastal ...

We’ve all seen the Viking commercials urging us to take one of those wonderful-looking voyages on the rivers of Europe. But ...